LIST OF TABLES
TABLE 01.GLOBAL LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 02.LIQUID BIOPSY MARKET FOR KITS & REAGENTS, BY REGION, 2020-2028 ($MILLION)
TABLE 03.LIQUID BIOPSY MARKET FOR PLATFORMS & INSTRUMENTS, BY REGION, 2020-2028 ($MILLION)
TABLE 04.LIQUID BIOPSY MARKET FOR SERVICES, BY REGION, 2020-2028 ($MILLION)
TABLE 05.LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 06.LIQUID BIOPSY MARKET FOR CIRCULATING TUMOR CELL, BY REGION, 2020-2028 ($MILLION)
TABLE 07.LIQUID BIOPSY MARKET FOR CIRCULATING TUMOR DNA, BY REGION, 2020-2028 ($MILLION)
TABLE 08.LIQUID BIOPSY MARKET FOR EXTRACELLULAR VESICLES, BY REGION, 2020-2028 ($MILLION)
TABLE 09.LIQUID BIOPSY MARKET FOR OTHERS, FOR OTHER BIOMARKERS, BY REGION, 2020-2028 ($MILLION)
TABLE 10.LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 11.LIQUID BIOPSY MARKET FOR LUNG CANCER, BY REGION, 2020-2028 ($MILLION)
TABLE 12.LIQUID BIOPSY MARKET FOR BREAST CANCER, BY REGION, 2020-2028 ($MILLION)
TABLE 13.LIQUID BIOPSY MARKET FOR COLORECTAL CANCER, BY REGION, 2020-2028 ($MILLION)
TABLE 14.LIQUID BIOPSY MARKET FOR PROSTATE CANCER, BY REGION, 2020-2028 ($MILLION)
TABLE 15.LIQUID BIOPSY MARKET FOR LIVER CANCER, BY REGION, 2020-2028 ($MILLION)
TABLE 16.LIQUID BIOPSY MARKET FOR OTHER CANCER, BY REGION, 2020-2028 ($MILLION)
TABLE 17.LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 18.LIQUID BIOPSY MARKET FOR HOSPITAL AND LABORATORY, BY REGION, 2020-2028 ($MILLION)
TABLE 19.LIQUID BIOPSY MARKET FOR GOVERNMENT AND ACADEMIC RESEARCH CENTER, BY REGION, 2020-2028 ($MILLION)
TABLE 20.LIQUID BIOPSY MARKET REVENUE, BY REGION, 2020-2028 ($MILLION)
TABLE 21.NORTH AMERICA LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 22.NORTH AMERICA LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 23.NORTH AMERICA LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 24.NORTH AMERICA LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 25.NORTH AMERICA LIQUID BIOPSY MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 26.U.S. LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 27.U.S. LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 28.U.S. LIQUID BIOPSY MARKET, BY CANCER TYPE , 2020-2028 ($MILLION)
TABLE 29.U.S. LIQUID BIOPSY MARKET, BY END USER , 2020-2028 ($MILLION)
TABLE 30.CANADA LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 31.CANADA LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 32.CANADA LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 33.CANADA LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 34.MEXICO LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 35.MEXICO LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 36.MEXICO. LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 37.MEXICO. LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 38.EUROPE LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 39.EUROPE LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 40.EUROPE LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 41.EUROPE LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 42.EUROPE LIQUID BIOPSY MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 43.GERMANY LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 44.GERMANY LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 45.GERMANY LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 46.GERMANY LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 47.FRANCE LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 48.FRANCE LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 49.FRANCE LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 50.FRANCE LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 51.UK LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 52.UK LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 53.UK LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 54.UK LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 55.ITALY LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 56.ITALY LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 57.ITALY LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 58.ITALY LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 59.SPAIN LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 60.SPAIN LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 61.SPAIN LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 62.SPAIN LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 63.REST OF EUROPE LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 64.REST OF EUROPE LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 65.REST OF EUROPE LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 66.REST OF EUROPE LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 67.ASIA-PACIFIC LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 68.ASIA-PACIFIC LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 69.ASIA-PACIFIC LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 70.ASIA-PACIFIC LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 71.ASIA-PACIFIC LIQUID BIOPSY MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 72.JAPAN LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 73.JAPAN LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 74.JAPAN LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 75.JAPAN LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 76.CHINA LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 77.CHINA LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 78.CHINA LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 79.CHINA LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 80.AUSTRALIA LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 81.AUSTRALIA LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 82.AUSTRALIA LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 83.AUSTRALIA LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 84.INDIA LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 85.INDIA LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 86.INDIA LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 87.INDIA LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 88.SOUTH KOREA LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 89.SOUTH KOREA LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 90.SOUTH KOREA LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 91.SOUTH KOREA LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 92.TAIWAN LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 93.TAIWAN LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 94.TAIWAN LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 95.TAIWAN LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 96.REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 97.REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 98.REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 99.REST OF ASIA-PACIFIC LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 100.LAMEA LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 101.LAMEA LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 102.LAMEA LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 103.LAMEA LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 104.LAMEA LIQUID BIOPSY MARKET, BY COUNTRY, 2020-2028 ($MILLION)
TABLE 105.BRAZIL LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 106.BRAZIL LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 107.BRAZIL LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 108.BRAZIL LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 109.TURKEY LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 110.TURKEY LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 111.TURKEY LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 112.TURKEY LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 113.SAUDI ARABIA LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 114.SAUDI ARABIA LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 115.SAUDI ARABIA LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 116.SAUDI ARABIA LIQUID BIOPSY MARKET, BY END USER, 2020-2028($MILLION)
TABLE 117.SOUTH AFRICA LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 118.SOUTH AFRICA LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 119.SOUTH AFRICA LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 120.SOUTH AFRICA LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 121.REST OF LAMEA LIQUID BIOPSY MARKET, BY PRODUCT & SERVICE, 2020-2028 ($MILLION)
TABLE 122.REST OF LAMEA LIQUID BIOPSY MARKET, BY CIRCULATING BIOMARKER, 2020-2028 ($MILLION)
TABLE 123.REST OF LAMEA LIQUID BIOPSY MARKET, BY CANCER TYPE, 2020-2028 ($MILLION)
TABLE 124.REST OF LAMEA LIQUID BIOPSY MARKET, BY END USER, 2020-2028 ($MILLION)
TABLE 125.BIO-RAD: COMPANY SNAPSHOT
TABLE 126.MYRIAD: OERATING SEGMENT
TABLE 127.BIO-RAD: PRODUCT PORTFOLIO
TABLE 128.BIO-RAD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 129.BIOCEPT: COMPANY SNAPSHOT
TABLE 130.BIOCEPT: PRODUCT PORTFOLIO
TABLE 131.BIOCEPT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 132.GUARDANT: COMPANY SNAPSHOT
TABLE 133.GUARDANT: OPERATING SEGMENTS
TABLE 134.GUARDANT: PRODUCT PORTFOLIO
TABLE 135.BIOCEPT: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 136.ILLUMINA: COMPANY SNAPSHOT
TABLE 137.ILLUMINA: OPERATING SEGMENTS
TABLE 138.ILLUMINA: PRODUCT PORTFOLIO
TABLE 139.ROCHE: COMPANY SNAPSHOT
TABLE 140.ROCHE: OPERATING SEGMENTS
TABLE 141.ROCHE: PRODUCT PORTFOLIO
TABLE 142.ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 143.J&J: COMPANY SNAPSHOT
TABLE 144.J&J: OPERATING BUSINESS SEGMENTS
TABLE 145.J&J: PRODUCT PORTFOLIO
TABLE 146.LABCORP: COMPANY SNAPSHOT
TABLE 147.LABCORP: OPERATING SEGMENTS
TABLE 148.LABCORP: PRODUCT PORTFOLIO
TABLE 149.ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 150.MDXHEALTH: COMPANY SNAPSHOT
TABLE 151.MDXHEALTH: PRODUCT PORTFOLIO
TABLE 152.ROCHE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 153.QIAGEN: COMPANY SNAPSHOT
TABLE 154.QIAGEN: PRODUCT PORTFOLIO
TABLE 155.QIAGEN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 156.THERMO: COMPANY SNAPSHOT
TABLE 157.THERMO: OPERATING SEGMENTS
TABLE 158.THERMO: PRODUCT PORTFOLIO
TABLE 159.THERMO: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURE
LIST OF FIGURES
FIGURE 01.GLOBAL LIQUID BIOPSYMARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 06.MODERATE BARGAINING POWER OF BUYERS
FIGURE 07.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 08.MODERATE THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE COMPETITIVE RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.PIE CHART FOR CANCER CASES DIAGNOSED IN 2020
FIGURE 13.COMPARATIVE SHARE ANALYSIS OF LIQUID BIOPSY MARKET FOR KITS & REAGENTS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 14.COMPARATIVE SHARE ANALYSIS OF LIQUID BIOPSY MARKET FOR PLATFORMS & INSTRUMENTS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 15.COMPARATIVE SHARE ANALYSIS OF LIQUID BIOPSY MARKET FOR SERVICES, BY COUNTRY, 2020 & 2028 (%)
FIGURE 16.COMPARATIVE ANALYSIS OF LIQUID BIOPSY MARKET FOR CIRCULATING TUMOR CELL, BY COUNTRY, 2020 & 2028 (%)
FIGURE 17.COMPARATIVE ANALYSIS OF LIQUID BIOPSY MARKET FOR CIRCULATING TUMOR DNA, BY COUNTRY, 2020 & 2028 (%)
FIGURE 18.COMPARATIVE ANALYSIS OF LIQUID BIOPSY MARKET FOR EXTRACELLULAR VESICLES, BY COUNTRY, 2020 & 2028 (%)
FIGURE 19.COMPARATIVE ANALYSIS OF LIQUID BIOPSY MARKET FOR OTHER BIOMARKERS, BY COUNTRY, 2020 & 2028 (%)
FIGURE 20.COMPARATIVE ANALYSIS OF LIQUID BIOPSY MARKET FOR LUNG CANCER, BY COUNTRY, 2020 & 2028 (%)
FIGURE 21.COMPARATIVE ANALYSIS OF LIQUID BIOPSY MARKET FOR BREAST CANCER, BY COUNTRY, 2020 & 2028 (%)
FIGURE 22.COMPARATIVE ANALYSIS OF LIQUID BIOPSY MARKET FOR COLORECTAL CANCER, BY COUNTRY, 2020 & 2028 (%)
FIGURE 23.COMPARATIVE ANALYSIS OF LIQUID BIOPSY MARKET FOR PROSTATE CANCER, BY COUNTRY, 2020 & 2028 (%)
FIGURE 24.COMPARATIVE ANALYSIS OF LIQUID BIOPSY MARKET FOR LIVER CANCER, BY COUNTRY, 2020 & 2028 (%)
FIGURE 25.COMPARATIVE ANALYSIS OF LIQUID BIOPSY MARKET FOR OTHER CANCER, BY COUNTRY, 2020 & 2028 (%)
FIGURE 26.COMPARATIVE ANALYSIS OF LIQUID BIOPSY MARKET FOR HOSPITAL AND LABORATORY, BY COUNTRY, 2020 & 2028 (%)
FIGURE 27.COMPARATIVE ANALYSIS OF LIQUID BIOPSY MARKET FOR GOVERNMENT AND ACADEMIC RESEARCH CENTER, BY COUNTRY, 2020 & 2028 (%)
FIGURE 28.BIO-RAD: NET SALES, 2018-2020 ($MILLION)
FIGURE 29.BIO-RAD: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 30.BIO-RAD: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 31.BIOCEPT: NET SALES, 2018-2020 ($MILLION)
FIGURE 32.GUARDANT: NET SALES, 2018-2020 ($MILLION)
FIGURE 33.GUARDANT: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 34.GUARDANT: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 35.ILLUMINA: NET SALES, 2018-2020 ($MILLION)
FIGURE 36.ILLUMINA: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 37.ILLUMINA: REVENUE SHARE BY REGION, 2020 (%)
FIGURE 38.ROCHE: NET SALES, 2018-2020 ($MILLION)
FIGURE 39.ROCHE: REVENUE SHARE, BY SEGMENT, 2020 ($MILLION)
FIGURE 40.J&J: NET SALES, 2018-2020 ($MILLION)
FIGURE 41.J&J: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 42.J&J: REVENUE SHARE BY REGION, 2020(%)
FIGURE 43.LABCORP: REVENUE, 2018-2020 ($MILLION)
FIGURE 44.LABCORP: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 45.LABCORP: REVENUE SHARE, BY REGION, 2020 (%)
FIGURE 46.MDXHEALTH: NET SALES, 2018-2020 ($MILLION)
FIGURE 47.MDXHEALTH: REVENUE SHARE BY REGION, 2020(%)
FIGURE 48.QIAGEN: NET SALES, 2018-2020 ($MILLION)
FIGURE 49.QIAGEN: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 50.THERMO: NET SALES, 2018-2020 ($MILLION)
FIGURE 51.THERMO: REVENUE SHARE, BY SEGMENT, 2020 (%)
FIGURE 52.THERMO: REVENUE SHARE, BY REGION, 2020 (%)
